Terms: = Gastric cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
9 results:
1. A degradome-related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma based on machine learning procedure.
Deng Z; Feng Q; Zhao D; Huang Z
Medicine (Baltimore); 2024 Apr; 103(15):e37728. PubMed ID: 38608069
[TBL] [Abstract] [Full Text] [Related]
2. Role of Collagen Gel Droplet-Embedded Culture-Drug Sensitivity Testing (CD-DST) for Assessing the Sensitivity of gastric cancer to Chemotherapy Drugs Combined with Other cancer Therapeutic Drugs.
Makino H; Nomura S; Kogo H; Wada N; Hayashi M; Yoshida H
J Nippon Med Sch; 2022 Aug; 89(4):412-421. PubMed ID: 35400719
[TBL] [Abstract] [Full Text] [Related]
3. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer.
Ma C; Storer CE; Chandran U; LaFramboise WA; Petrosko P; Frank M; Hartman DJ; Pantanowitz L; Haritunians T; Head RD; Liu TC
EBioMedicine; 2021 May; 67():103347. PubMed ID: 33906066
[TBL] [Abstract] [Full Text] [Related]
4. Microsatellite instability status differentially associates with intratumoral immune microenvironment in human cancers.
Zhang P; Liu M; Cui Y; Zheng P; Liu Y
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32823273
[TBL] [Abstract] [Full Text] [Related]
5. Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis.
Park R; Lopes L; Saeed A
Clin Transl Oncol; 2021 Jan; 23(1):100-109. PubMed ID: 32495269
[TBL] [Abstract] [Full Text] [Related]
6. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
[TBL] [Abstract] [Full Text] [Related]
7. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
Lin SJ; Gagnon-Bartsch JA; Tan IB; Earle S; Ruff L; Pettinger K; Ylstra B; van Grieken N; Rha SY; Chung HC; Lee JS; Cheong JH; Noh SH; Aoyama T; Miyagi Y; Tsuburaya A; Yoshikawa T; Ajani JA; Boussioutas A; Yeoh KG; Yong WP; So J; Lee J; Kang WK; Kim S; Kameda Y; Arai T; Zur Hausen A; Speed TP; Grabsch HI; Tan P
Gut; 2015 Nov; 64(11):1721-31. PubMed ID: 25385008
[TBL] [Abstract] [Full Text] [Related]
8. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
Kono K; Kawaida H; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Fujii H
Cancer Immunol Immunother; 2006 Sep; 55(9):1064-71. PubMed ID: 16328385
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract] [Full Text] [Related]
